Outset Medical, Inc. APIC, Share-based Payment Arrangement, Increase for Cost Recognition
Outset Medical, Inc. (OM) reported APIC, Share-based Payment Arrangement, Increase for Cost Recognition of $2.70 million for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-06.
Financial Statements › Shareholders' Equity
us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue · last filed 2026-08-06
- Outset Medical, Inc. apic, share-based payment arrangement, increase for cost recognition for the quarter ending 2026-06-30 was $2.70M, a 22.88% decline year-over-year.
- Outset Medical, Inc. apic, share-based payment arrangement, increase for cost recognition for the quarter ending 2026-03-31 was $3.45M, a 15.99% increase year-over-year.
- Outset Medical, Inc. apic, share-based payment arrangement, increase for cost recognition for the quarter ending 2025-09-30 was $5.08M, a 20.48% decline year-over-year.
- Outset Medical, Inc. apic, share-based payment arrangement, increase for cost recognition for the quarter ending 2025-06-30 was $3.50M, a 64.40% decline year-over-year.
- Outset Medical, Inc. apic, share-based payment arrangement, increase for cost recognition for fiscal 2025 was $15.62M, a 46.80% decline from fiscal 2024.
- Outset Medical, Inc. apic, share-based payment arrangement, increase for cost recognition for fiscal 2024 was $29.36M, a 24.02% decline from fiscal 2023.
- Outset Medical, Inc. apic, share-based payment arrangement, increase for cost recognition for fiscal 2023 was $38.63M, a 42.02% increase from fiscal 2022.
- Outset Medical, Inc. apic, share-based payment arrangement, increase for cost recognition for fiscal 2022 was $27.20M, a 55.94% increase from fiscal 2021.
| Period end | APIC, Share-based Payment Arrangement, Increase for Cost Recognition 3 month | APIC, Share-based Payment Arrangement, Increase for Cost Recognition 6 month | APIC, Share-based Payment Arrangement, Increase for Cost Recognition 9 month | APIC, Share-based Payment Arrangement, Increase for Cost Recognition 12 month |
|---|---|---|---|---|
| 2026-06-30 | $2.70M 10-Q · filed 2026-08-06 | $6.15M derived: sum of 2 quarters · filed 2026-08-06 | ||
| 2026-03-31 | $3.45M 10-Q · filed 2026-08-06 | |||
| 2025-12-31 | $15.62M 10-K · filed 2026-02-13 | |||
| 2025-09-30 | $5.08M 10-Q · filed 2025-11-10 | $8.58M derived: sum of 2 quarters · filed 2026-08-06 | $11.55M derived: sum of 3 quarters · filed 2026-08-06 | |
| 2025-06-30 | $3.50M 10-Q · filed 2026-08-06 | $6.47M derived: sum of 2 quarters · filed 2026-08-06 | ||
| 2025-03-31 | $2.98M 10-Q · filed 2026-08-06 | |||
| 2024-12-31 | $29.36M 10-K · filed 2026-02-13 | |||
| 2024-09-30 | $6.39M 10-Q · filed 2025-11-10 | $16.21M derived: sum of 2 quarters · filed 2025-11-10 | $24.41M derived: sum of 3 quarters · filed 2025-11-10 | |
| 2024-06-30 | $9.82M 10-Q · filed 2025-11-10 | $18.02M derived: sum of 2 quarters · filed 2025-11-10 | ||
| 2024-03-31 | $8.20M 10-Q · filed 2025-11-10 | |||
| 2023-12-31 | $38.63M 10-K · filed 2026-02-13 | |||
| 2023-09-30 | $10.89M 10-Q · filed 2024-11-07 | $21.00M derived: sum of 2 quarters · filed 2024-11-07 | $29.54M derived: sum of 3 quarters · filed 2024-11-07 | |
| 2023-06-30 | $10.11M 10-Q · filed 2024-11-07 | $18.64M derived: sum of 2 quarters · filed 2024-11-07 | ||
| 2023-03-31 | $8.54M 10-Q · filed 2024-11-07 | |||
| 2022-12-31 | $27.20M 10-K · filed 2025-02-28 | |||
| 2022-09-30 | $7.43M 10-Q · filed 2023-11-08 | $14.84M derived: sum of 2 quarters · filed 2023-11-08 | $19.85M derived: sum of 3 quarters · filed 2023-11-08 | |
| 2022-06-30 | $7.41M 10-Q · filed 2023-11-08 | $12.42M derived: sum of 2 quarters · filed 2023-11-08 | ||
| 2022-03-31 | $5.01M 10-Q · filed 2023-11-08 | |||
| 2021-12-31 | $17.45M 10-K · filed 2024-02-21 | |||
| 2021-09-30 | $2.86M 10-Q · filed 2022-11-09 | $6.80M derived: sum of 2 quarters · filed 2022-11-09 | $12.65M derived: sum of 3 quarters · filed 2022-11-09 | |
| 2021-06-30 | $3.94M 10-Q · filed 2022-11-09 | $9.79M derived: sum of 2 quarters · filed 2022-11-09 | ||
| 2021-03-31 | $5.85M 10-Q · filed 2022-11-09 | |||
| 2020-12-31 | $21.44M 10-K · filed 2023-02-13 | |||
| 2020-09-30 | $13.91M 10-Q · filed 2021-11-04 | $14.59M derived: sum of 2 quarters · filed 2021-11-04 | $15.17M derived: sum of 3 quarters · filed 2021-11-04 | |
| 2020-06-30 | $683.00K 10-Q · filed 2021-11-04 | $1.26M derived: sum of 2 quarters · filed 2021-11-04 | ||
| 2020-03-31 | $580.00K 10-Q · filed 2021-11-04 | |||
| 2019-12-31 | $883.00K 10-K · filed 2022-02-23 | |||
| 2019-09-30 | $236.00K 10-Q · filed 2020-11-12 | $397.00K derived: sum of 2 quarters · filed 2020-11-12 | $636.00K derived: sum of 3 quarters · filed 2020-11-12 | |
| 2019-06-30 | $161.00K 10-Q · filed 2020-11-12 | $400.00K derived: sum of 2 quarters · filed 2020-11-12 | ||
| 2019-03-31 | $239.00K 10-Q · filed 2020-11-12 | |||
| 2018-12-31 | $788.00K 10-K · filed 2021-03-22 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| PRECISION OPTICS CORPORATION, INC. (POCI) | United States | $0.052B | |
| QT IMAGING HOLDINGS, INC. (QTI) | United States | $0.037B | |
| Streamex Corp. (STEX) | United States | $0.089B | -0.19 |
| Nexalin Technology, Inc. (NXL) | United States | $0.094B | |
| Neuraxis, INC (NRXS) | United States | $0.097B | |
| electroCore, Inc. (ECOR) | United States | $0.102B | |
| IRIDEX CORP (IRIX) | United States | $0.011B | |
| ENDRA Life Sciences Inc. (NDRA) | United States | $0.009B | |
| Vivani Medical, Inc. (VANI) | United States | $0.111B | |
| Nuwellis, Inc. (NUWE) | United States | $0.003B |